New bilateral gene therapy shows promising results in treating genetic hearing loss

FHS
June 5, 2024
6:23 pm

A novel gene therapy designed to target a form of inherited deafness restored hearing function in five children who were treated in both ears.

They came to America looking for better lives – and better schools. The results were mixed. – The Cannabist

AURORA — Starting seventh grade at her first American school, facing classes taught entirely in English, Alisson Ramirez steeled herself for rejection and months of

October 27, 2024

FDA OKs New Frontline Endometrial Cancer Regimen, First in Decades

The FDA approved the immune checkpoint inhibitor dostarlimab (Jemperli) plus chemotherapy as a frontline option for certain patients with advanced or recurrent endometrial cancer, the

August 1, 2023

Risk Adjusted Net Present Value: What is the current valuation of Unicycive Therapeutics’s RenaZorb

The revenue for RenaZorb is expected to reach an annual total of $308 mn by 2026 in the US based off GlobalData’s Expiry Model. The

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.